Skip to main content Skip to navigation

Disease modifying drug therapy

Published May 2009

Contents
Introduction
What are disease modifying drugs and what do they do?
What to expect from disease modifying drugs
Other drugs used in MS other
Further sources of information and support

Acknowledgments

We would like to thank the people with MS who reviewed this book, as well as representatives from each of the pharmaceutical manufacturers and the following specialist nurses: Samantha Colhoun, University Hospital Birmingham, West Midlands, Nikki Embrey, North Staffordshire University Hospital, Stoke-on-Trent, Gail Hayes, Mardon Neuro-Rehabilitation Centre, Exeter, Alan Izat, Douglas Grant Rehabilitation Centre, Scotland; Andrew Jones, Royal Alexandra Hospital, Denbighshire, Wales; Deborah Macmillan, Darent Valley Hospital, Kent, Heidi Thompson, Craigavon Area Hospital, Northern Ireland; Bronwyn Roper, Norfolk and Norwich University Hospital, Norwich.